Sen. John Boozman Sells UnitedHealth Group Incorporated (NYSE:UNH) Shares

Senator John Boozman (R-Arkansas) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on July 09th, the Senator disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on June 11th.

Senator John Boozman also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Micron Technology NASDAQ: MU on 6/11/2025.
• Purchased $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 6/11/2025.
• Purchased $1,001 - $15,000 in shares of Invesco Short Term Treasury ETF NYSEARCA: TBLL on 6/11/2025.
• Sold $1,001 - $15,000 in shares of Fortune Brands Innovations NYSE: FBIN on 5/30/2025.
• Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 5/30/2025.
• Purchased $1,001 - $15,000 in shares of RTX NYSE: RTX on 5/30/2025.
• Purchased $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOGL on 5/20/2025.
• Sold $1,001 - $15,000 in shares of NRG Energy NYSE: NRG on 5/20/2025.
• Sold $1,001 - $15,000 in shares of General Dynamics NYSE: GD on 5/20/2025.
• Sold $1,001 - $15,000 in shares of DTE Energy NYSE: DTE on 5/20/2025.

UnitedHealth Group Trading Down 2.0%

Shares of UNH stock opened at $282.45 on Friday. The firm has a 50-day moving average price of $304.47 and a 200 day moving average price of $432.89. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a market capitalization of $256.22 billion, a price-to-earnings ratio of 11.83, a PEG ratio of 1.38 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period last year, the company posted $6.91 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 3.13%. UnitedHealth Group's payout ratio is currently 37.02%.

Hedge Funds Weigh In On UnitedHealth Group

A number of institutional investors have recently bought and sold shares of UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the 4th quarter valued at about $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $28,000. Bayforest Capital Ltd grew its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. Finally, Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after buying an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on UNH shares. Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. Oppenheimer reduced their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. Erste Group Bank cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Royal Bank Of Canada reduced their price objective on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Finally, Barclays restated an "overweight" rating on shares of UnitedHealth Group in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $394.43.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director owned 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the acquisition, the chief executive officer owned 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 over the last quarter. Insiders own 0.28% of the company's stock.

About Senator Boozman

John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas' U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman's academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.